BioCentury
ARTICLE | Company News

Allergan, Ironwood sales and marketing update

January 18, 2016 8:00 AM UTC

Allergan launched Viberzi eluxadoline in the U.S. to treat irritable bowel syndrome with diarrhea (IBS-D). The wholesale acquisition cost (WAC) for Viberzi is $16 per 75 and 100 mg tablet. The recomm...